{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:43:46Z","timestamp":1776901426194,"version":"3.51.2"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T00:00:00Z","timestamp":1445299200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1038\/nrgastro.2015.174","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T14:32:12Z","timestamp":1445351532000},"page":"711-719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The evolving concept of acute kidney injury in patients with cirrhosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Florence","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"BFnrgastro2015174_CR1","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/hep.22605","volume":"48","author":"G Garcia-Tsao","year":"2008","unstructured":"Garcia-Tsao, G., Parikh, C. R. & Viola, A. Acute kidney injury in cirrhosis. Hepatology 48, 2064\u20132077 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro2015174_CR2","first-page":"1310","volume":"56","author":"F Salerno","year":"2007","unstructured":"Salerno, F., Gerbes, A., Gin\u00e8s, P., Wong, F. & Arroyo, V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 56, 1310\u20131318 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","volume":"362","author":"P Gin\u00e8s","year":"2003","unstructured":"Gin\u00e8s, P., Guevara, M., Arroyo, V. & Rod\u00e9s, J. Hepatorenal syndrome. Lancet 362, 1819\u20131827 (2003).","journal-title":"Lancet"},{"key":"BFnrgastro2015174_CR4","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","volume":"55","author":"F Salerno","year":"2011","unstructured":"Salerno, F.  et al. Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice. J. Hepatol. 55, 1241\u20131248 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR5","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","volume":"134","author":"AJ Sanyal","year":"2008","unstructured":"Sanyal, A. J.  et al. A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology 134, 1360\u20131368 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015174_CR6","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","volume":"134","author":"M Mart\u00edn-Llah\u00ed","year":"2008","unstructured":"Mart\u00edn-Llah\u00ed, M.  et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology 134, 1352\u20131359 (2008).","journal-title":"Gastroenterology"},{"issue":"Suppl. 1","key":"BFnrgastro2015174_CR7","first-page":"255A","volume":"60","author":"TD Boyer","year":"2014","unstructured":"Boyer, T. D.  et al. Initial report of a large, randomized, double blind, placebo-controlled, phase 3 trial of terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome (HRS-1): the REVERSE Study. Hepatology 60 (Suppl. 1), 255A (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2015174_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","volume":"55","author":"TD Boyer","year":"2011","unstructured":"Boyer, T. D.  et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. J. Hepatol. 55, 315\u2013321 (2011).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR9","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.jhep.2014.02.001","volume":"60","author":"C Francoz","year":"2014","unstructured":"Francoz, C. & Durand, F. Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. sepsis-induced acute kidney injury: what matters? J. Hepatol. 60, 907\u2013909 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","volume":"60","author":"E Rodr\u00edguez","year":"2014","unstructured":"Rodr\u00edguez, E.  et al. Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. J. Hepatol. 60, 955\u2013961 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR11","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/ki.2014.338","volume":"87","author":"D Adebayo","year":"2015","unstructured":"Adebayo, D., Morabito, V., Davenport, A. & Jalan, R. Renal dysfunction in cirrhosis is not just a vasomotor nephropathy. Kidney Int. 87, 509\u2013515 (2015).","journal-title":"Kidney Int."},{"key":"BFnrgastro2015174_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4292\/wjgpt.v5.i3.156","volume":"5","author":"C Pipili","year":"2014","unstructured":"Pipili, C. & Cholongitas, E. Renal dysfunction in patients with cirrhosis: where do we stand? World J. Gastrointest. Pharmacol. Ther. 5, 156\u2013168 (2014).","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"BFnrgastro2015174_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.27.4.519","volume":"27","author":"WD Macnider","year":"1918","unstructured":"Macnider, W. D. A study of acute mercuric chloride intoxications in the dog with special reference to the kidney injury. J. Exp. Med. 27, 519\u2013538 (1918).","journal-title":"J. Exp. Med."},{"key":"BFnrgastro2015174_CR14","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/cc2872","volume":"8","author":"R Bellomo","year":"2004","unstructured":"Bellomo, R., Ronco, C., Kellum, J. A., Mehta, R. L. & Palevsky, P. Acute Dialysis Quality Initiative workgroup. Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit. Care. 8, R204\u2013R212 (2004).","journal-title":"Crit. Care."},{"key":"BFnrgastro2015174_CR15","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/cc4915","volume":"10","author":"EA Hoste","year":"2006","unstructured":"Hoste, E. A.  et al. RIFLE criteria for acute kidney injury is associated with hospital mortality in critical ill patients: a cohort analysis. Crit. Care 10, R73 (2006).","journal-title":"Crit. Care"},{"key":"BFnrgastro2015174_CR16","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1681\/ASN.2006070756","volume":"18","author":"T Ali","year":"2007","unstructured":"Ali, T.  et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J. Am. Soc. Nephrol. 18, 1292\u20131298 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrgastro2015174_CR17","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta, R. L.  et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit. Care. 11, R31 (2007).","journal-title":"Crit. Care."},{"key":"BFnrgastro2015174_CR18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/01.ASN.0000130340.93930.DD","volume":"15","author":"A Lassnigg","year":"2004","unstructured":"Lassnigg, A.  et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J. Am. Soc. Nephrol. 15, 1597\u20131605 (2004).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrgastro2015174_CR19","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/s00134-009-1530-4","volume":"35","author":"M Joannidis","year":"2009","unstructured":"Joannidis, M.  et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 35, 1692\u20131702 (2009).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2015174_CR20","unstructured":"International Society of Nephrology. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. Suppl. 2, S1\u2013S138 (2012)."},{"key":"BFnrgastro2015174_CR21","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s00134-007-0760-6","volume":"33","author":"CC Jenq","year":"2007","unstructured":"Jenq, C. C.  et al. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med. 33, 1921\u20131930 (2007).","journal-title":"Intensive Care Med."},{"key":"BFnrgastro2015174_CR22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/j.1440-1746.2009.05908.x","volume":"24","author":"E Cholongitas","year":"2009","unstructured":"Cholongitas, E.  et al. RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J. Gastroenterol. Hepatol. 24, 1639\u20131647 (2009).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015174_CR23","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1111\/liv.12852","volume":"35","author":"S Rosi","year":"2015","unstructured":"Rosi, S.  et al. New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? Liver Int. 35, 2108\u20132114 (2015).","journal-title":"Liver Int."},{"key":"BFnrgastro2015174_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.jhep.2009.11.025","volume":"52","author":"C Francoz","year":"2010","unstructured":"Francoz, C., Glotz, D., Moreau, R. & Durand, F. The evaluation of renal function and disease in patients with cirrhosis. J. Hepatol. 52, 605\u2013613 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR25","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1002\/lt.22128","volume":"16","author":"C Francoz","year":"2010","unstructured":"Francoz, C.  et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the Model for End-Stage Liver Disease score. Liver Transpl. 16, 1169\u20131177 (2010).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015174_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1440-1746.2011.06925.x","volume":"27","author":"F Wong","year":"2012","unstructured":"Wong, F. Management of ascites in cirrhosis. J. Gastroenterol. Hepatol. 27, 11\u201320 (2012).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015174_CR27","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/gut.2010.236133","volume":"60","author":"F Wong","year":"2011","unstructured":"Wong, F.  et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60, 702\u2013709 (2011).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR28","first-page":"341","volume":"51","author":"R Orlando","year":"1999","unstructured":"Orlando, R.  et al. Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis. Clin. Nephrol. 51, 341\u2013347 (1999).","journal-title":"Clin. Nephrol."},{"key":"BFnrgastro2015174_CR29","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","volume":"41","author":"DS Sherman","year":"2003","unstructured":"Sherman, D. S., Fish, D. N. & Teitelbaum, I. Assessing renal function in cirrhotic patients: problems and pitfalls. Am. J. Kidney Dis. 41, 269\u2013278 (2003).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrgastro2015174_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","volume":"62","author":"CD Tsien","year":"2013","unstructured":"Tsien, C. D., Rabie, R. & Wong, F. Acute kidney injury in decompensated cirrhosis. Gut 62, 131\u2013137 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR31","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1136\/gutjnl-2013-304907.240","volume":"62","author":"C Tsien","year":"2013","unstructured":"Tsien, C. & Wong, F. The impact of acute kidney injury in cirrhosis: does definition matter? Gut 62, 1091\u20131092 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR32","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","volume":"145","author":"F Wong","year":"2013","unstructured":"Wong, F.  et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology 145, 1280\u20131289 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2015174_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/hep.25735","volume":"57","author":"JM Belcher","year":"2013","unstructured":"Belcher, J. M.  et al. Association of AKI with mortality and complications in hospitalized patients with cirrhosis. Hepatology 57, 753\u2013762 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro2015174_CR34","doi-asserted-by":"publisher","first-page":"Siii451","DOI":"10.1093\/ndt\/gfv190.34","volume":"30","author":"F Wong","year":"2015","unstructured":"Wong, F.  et al. Reduction in acute kidney injury (AKI) stage is a strong predictor of survival in patients with hepatorenal syndrome type-1 (HRS-1) treated with terlipressin plus albumin or albumin alone. Nephrol. Dial. Transplant. 30, Siii451 (2015).","journal-title":"Nephrol. Dial. Transplant."},{"key":"BFnrgastro2015174_CR35","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cgh.2011.09.011","volume":"10","author":"J Altamirano","year":"2012","unstructured":"Altamirano, J.  et al. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin. Gastroenterol. Hepatol. 10, 65\u201371 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015174_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1136\/flgastro-2012-100291","volume":"4","author":"RA Scott","year":"2013","unstructured":"Scott, R. A., Austin, A. S., Kolhe, N. V., McIntyre, C. W. & Selby, N. M. Acute kidney injury is independently associated with death in patients with cirrhosis. Frontline Gastroenterol. 4, 191\u2013197 (2013).","journal-title":"Frontline Gastroenterol."},{"key":"BFnrgastro2015174_CR37","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jhep.2013.05.035","volume":"59","author":"V Arroyo","year":"2013","unstructured":"Arroyo, V. Acute kidney injury (AKI) in cirrhosis: should we change current definition and diagnostic criteria of renal failure in cirrhosis? J. Hepatol. 59, 415\u2013417 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/S1665-2681(19)31307-9","volume":"12","author":"A Cardenas","year":"2013","unstructured":"Cardenas A. Defining renal failure in cirrhosis\u2014acute kidney injury classification or traditional criteria? Ann. Hepatol. 12, 984\u2013985 (2013).","journal-title":"Ann. Hepatol."},{"key":"BFnrgastro2015174_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM199908053410603","volume":"341","author":"P Sort","year":"1999","unstructured":"Sort, P.  et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N. Engl. J. Med. 341, 403\u2013409 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2015174_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/gut.2008.176495","volume":"59","author":"P Angeli","year":"2010","unstructured":"Angeli, P.  et al. Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomized clinical trial. Gut 59, 98\u2013104 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","volume":"59","author":"S Piano","year":"2013","unstructured":"Piano, S.  et al. Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. J. Hepatol. 59, 482\u2013489 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR42","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","volume":"59","author":"C Fagundes","year":"2013","unstructured":"Fagundes, C.  et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J. Hepatol. 59, 474\u2013481 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jhep.2014.10.047","volume":"62","author":"F Wong","year":"2015","unstructured":"Wong, F.  et al. A cut-off serum creatinine value of 1.5mg\/dl for AKI \u2014to be or not to be. J. Hepatol. 62, 741\u2013743 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR44","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jhep.2013.10.036","volume":"60","author":"U Thalhemier","year":"2014","unstructured":"Thalhemier, U. & Burroughs, A. K. To close the stable door before the horse has bolted. J. Hepatol. 60, 678\u2013679 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR45","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jhep.2014.12.001","volume":"62","author":"S Piano","year":"2015","unstructured":"Piano, S.  et al. Reply to: \u201cA cut-off serum creatinine value of 1.5mg\/dl for AKI \u2014 to be or not to be\u201d. J. Hepatol. 62, 744\u2013746 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR46","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2014.11.039","volume":"62","author":"C Fagundes","year":"2015","unstructured":"Fagundes, C.  et al. Reply to: \u201cA cut-off serum creatinine value of 1.5mg\/dl for AKI \u2014 to be or not to be\u201d. J. Hepatol. 62, 743\u2013744 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR47","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1016\/S0168-8278(15)30418-9","volume":"62","author":"F Wong","year":"2015","unstructured":"Wong, F.  et al. Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcome. J. Hepatol. 62, S380 (2015).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","volume":"64","author":"P Angeli","year":"2015","unstructured":"Angeli, P.  et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut 64, 531\u2013537 (2015).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000349963","volume":"182","author":"MC McCullough","year":"2013","unstructured":"McCullough, M. C.  et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib. Nephrol. 182, 13\u201329 (2013).","journal-title":"Contrib. Nephrol."},{"key":"BFnrgastro2015174_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/ki.2013.374","volume":"85","author":"PT Murray","year":"2014","unstructured":"Murray, P. T.  et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 85, 513\u2013521 (2014).","journal-title":"Kidney Int."},{"key":"BFnrgastro2015174_CR51","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.27063","volume":"60","author":"F Wong","year":"2014","unstructured":"Wong, F. & Murray, P. Kidney damage biomarkers: novel tools for the diagnostic assessment of acute kidney injury in cirrhosis. Hepatology 60, 455\u2013457 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2015174_CR52","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1681\/ASN.2010121302","volume":"22","author":"CR Parikh","year":"2011","unstructured":"Parikh, C. R.  et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J. Am. Soc. Nephrol. 22, 1748\u20131757 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrgastro2015174_CR53","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2215\/CJN.09061209","volume":"5","author":"ED Siew","year":"2010","unstructured":"Siew, E. D.  et al. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin. J. Am. Soc. Nephrol. 5, 1497\u20131505 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"BFnrgastro2015174_CR54","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1053\/j.ajkd.2008.01.020","volume":"52","author":"D Bolignano","year":"2008","unstructured":"Bolignano, D.  et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am. J. Kidney Dis. 52, 595\u2013605 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrgastro2015174_CR55","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","volume":"57","author":"EC Verna","year":"2012","unstructured":"Verna, E. C.  et al. Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis. Dig. Dis. Sci. 57, 2362\u20132370 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2015174_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","volume":"57","author":"C Fagundes","year":"2012","unstructured":"Fagundes, C.  et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J. Hepatol. 57, 267\u2013273 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR57","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","volume":"61","author":"R Barreto","year":"2014","unstructured":"Barreto, R.  et al. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. J. Hepatol. 61, 35\u201342 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR58","doi-asserted-by":"publisher","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","volume":"10","author":"X Ariza","year":"2015","unstructured":"Ariza, X.  et al. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS ONE 10, e0128145 (2015).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2015174_CR59","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.26980","volume":"60","author":"J Belcher","year":"2014","unstructured":"Belcher. J.  et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 60, 622\u2013632 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2015174_CR60","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1478-3231.2009.02182.x","volume":"30","author":"JM Trawal\u00e9","year":"2010","unstructured":"Trawal\u00e9, J. M.  et al. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int. 30, 725\u2013732 (2010).","journal-title":"Liver Int."},{"key":"BFnrgastro2015174_CR61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nrgastro.2012.96","volume":"9","author":"F Wong","year":"2012","unstructured":"Wong, F. Recent advances in our understanding of hepatorenal syndrome. Nat. Rev. Gastroenterol. Hepatol. 9, 382\u2013391 (2012).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2015174_CR62","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/hep.21920","volume":"46","author":"D Thabut","year":"2007","unstructured":"Thabut, D.  et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 46, 1872\u20131882 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2015174_CR63","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/lt.24049","volume":"21","author":"F Wong","year":"2015","unstructured":"Wong, F., Leung, W., Al Beshir, M., Marquez, M. & Renner, E. L. Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation. Liver Transpl. 21, 300\u2013307 (2015).","journal-title":"Liver Transpl."},{"key":"BFnrgastro2015174_CR64","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1136\/gut.2008.154120","volume":"58","author":"JA Leithead","year":"2009","unstructured":"Leithead, J. A.  et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 58, 443\u2013449 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2015174_CR65","doi-asserted-by":"publisher","first-page":"H768","DOI":"10.1152\/ajpheart.00779.2014","volume":"307","author":"CF Wenceslau","year":"2015","unstructured":"Wenceslau, C. F., McCarthy, C. G., Szasz, T., Goulopoulou, S. & Webb, R. C. Mitochondrial N-formyl peptides induce cardiovascular collapse and sepsis-like syndrome. Am. J. Physiol. Heart Circ. Physiol. 307, H768\u2013H777 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrgastro2015174_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","volume":"41","author":"H Gomez","year":"2014","unstructured":"Gomez, H.  et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 41, 3\u201311 (2014).","journal-title":"Shock"},{"key":"BFnrgastro2015174_CR67","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/liv.12528","volume":"35","author":"R Garcia-Martinez","year":"2015","unstructured":"Garcia-Martinez, R., Noiret, L., Sen, S., Mookerjee, R. & Jalan, R. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury. Liver Int. 35, 335\u2013343 (2015).","journal-title":"Liver Int."},{"key":"BFnrgastro2015174_CR68","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","volume":"56","author":"N Shah","year":"2012","unstructured":"Shah, N.  et al. Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. J. Hepatol. 56, 1047\u20131053 (2012).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2015174_CR69","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/liv.12047","volume":"33","author":"N Shah","year":"2013","unstructured":"Shah, N.  et al. Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis. Liver Int. 33, 398\u2013409 (2013).","journal-title":"Liver Int."},{"key":"BFnrgastro2015174_CR70","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/hep.510230122","volume":"23","author":"V Arroyo","year":"1996","unstructured":"Arroyo, V.  et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 23, 164\u2013176 (1996).","journal-title":"Hepatology"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.174","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2015.174.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:52:57Z","timestamp":1684468377000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2015.174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,20]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["BFnrgastro2015174"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2015.174","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,20]]},"assertion":[{"value":"20 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}